357 results
Page 5 of 18
10-K
EX-10.32
61cdda8yxgrihsr5xj
12 Feb 18
Annual report
12:00am
10-K
EX-10.43
uhj2l9eai7gz
12 Feb 18
Annual report
12:00am
10-K
EX-10.49
tm0l7
12 Feb 18
Annual report
12:00am
10-K
EX-10.50
pw41v 4lb5c
12 Feb 18
Annual report
12:00am
10-K
EX-10.7
254f xcst
12 Feb 18
Annual report
12:00am
10-K
EX-10.22
0veji2v1lvipbb2vpbwi
12 Feb 18
Annual report
12:00am
6-K
EX-4.2
6wikp6jv5mp6 pq3
25 Jul 16
Current report (foreign)
12:00am
6-K
k6jbmo9m38ywzvq6
20 Jul 16
Current report (foreign)
12:00am
424B5
4lhvk1z1
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
c6ey2 xyc
13 Jul 16
Current report (foreign)
12:00am
6-K
68he6v 83cy
30 Nov 15
Current report (foreign)
12:00am
424B5
wtajj
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
80pzdhbg
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
b3749ch3ycn3
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
258geslxb 2dbha
18 Jun 14
Current report (foreign)
12:00am